Medidata Solutions (MDSO) Stock Price Down 5.7%

Medidata Solutions Inc (NASDAQ:MDSO)’s share price traded down 5.7% during mid-day trading on Thursday . The stock traded as low as $59.60 and last traded at $62.61. 3,125,791 shares changed hands during mid-day trading, an increase of 417% from the average session volume of 604,781 shares. The stock had previously closed at $66.38.

Several equities analysts recently issued reports on the stock. Morgan Stanley dropped their target price on shares of Medidata Solutions from $86.00 to $79.00 and set an “overweight” rating on the stock in a report on Friday. SunTrust Banks restated a “buy” rating and issued a $92.00 target price on shares of Medidata Solutions in a report on Friday, October 27th. Deutsche Bank assumed coverage on shares of Medidata Solutions in a report on Friday, December 8th. They issued a “buy” rating and a $78.00 target price on the stock. BidaskClub upgraded shares of Medidata Solutions from a “sell” rating to a “hold” rating in a report on Tuesday, January 16th. Finally, TheStreet lowered shares of Medidata Solutions from a “b” rating to a “c+” rating in a report on Thursday, December 14th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and eleven have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $83.00.

The firm has a market cap of $3,660.24, a price-to-earnings ratio of 87.80, a price-to-earnings-growth ratio of 3.24 and a beta of 1.58. The company has a debt-to-equity ratio of 0.20, a quick ratio of 3.37 and a current ratio of 1.50.

Medidata Solutions (NASDAQ:MDSO) last announced its quarterly earnings data on Thursday, February 8th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.31 by $0.10. Medidata Solutions had a net margin of 8.14% and a return on equity of 11.59%. The firm had revenue of $141.20 million for the quarter, compared to analyst estimates of $140.65 million. During the same quarter in the prior year, the business earned $0.33 earnings per share. The business’s quarterly revenue was up 13.4% compared to the same quarter last year. analysts expect that Medidata Solutions Inc will post 0.93 earnings per share for the current year.

In other news, COO Michael L. Capone sold 5,000 shares of the business’s stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $66.33, for a total transaction of $331,650.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Rouven Bergmann sold 2,000 shares of the business’s stock in a transaction dated Thursday, November 30th. The stock was sold at an average price of $65.40, for a total transaction of $130,800.00. Following the sale, the chief financial officer now directly owns 91,775 shares of the company’s stock, valued at $6,002,085. The disclosure for this sale can be found here. Insiders have sold 29,010 shares of company stock worth $1,962,206 in the last quarter. Company insiders own 5.80% of the company’s stock.

Several large investors have recently bought and sold shares of the company. 1st Global Advisors Inc. increased its position in shares of Medidata Solutions by 0.5% during the second quarter. 1st Global Advisors Inc. now owns 8,243 shares of the company’s stock worth $645,000 after acquiring an additional 37 shares in the last quarter. Bank of Nova Scotia increased its position in shares of Medidata Solutions by 7.7% during the second quarter. Bank of Nova Scotia now owns 8,365 shares of the company’s stock worth $654,000 after acquiring an additional 600 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in shares of Medidata Solutions by 11.0% during the third quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 8,534 shares of the company’s stock worth $666,000 after acquiring an additional 847 shares in the last quarter. Essex Investment Management Co. LLC increased its position in shares of Medidata Solutions by 8.7% during the fourth quarter. Essex Investment Management Co. LLC now owns 11,085 shares of the company’s stock worth $702,000 after acquiring an additional 886 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Medidata Solutions by 48.3% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,242 shares of the company’s stock worth $205,000 after acquiring an additional 1,056 shares in the last quarter. 97.52% of the stock is owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Medidata Solutions (MDSO) Stock Price Down 5.7%” was originally reported by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international copyright and trademark laws. The correct version of this report can be viewed at https://www.com-unik.info/2018/02/10/medidata-solutions-mdso-stock-price-down-5-7.html.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.

Receive News & Ratings for Medidata Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit